28 May 2008
BOXMEER (the Netherlands), May 27, 2008 – Intervet/Schering-Plough Animal Health appointed the Heads of Global Species teams for the swine, the poultry and the aquaculture segment. These appointments are an important step in the design process of the combined Animal Health organization. The heads of the Global Species teams report to Ruurd Stolp, Senior Vice President and President Animal Health.
Appointed as Heads of the Global Species teams are:
Ruud Aerdts: Head of Global Poultry;
Mr. Aerdts has held the position of Head of Global Marketing-Poultry for Intervet since 2005. Prior to this, he held General Manager positions for the company in Thailand and Indonesia. Mr. Aerdts completed an Executive MBA program with NIMBAS Graduate School of Management, Utrecht, The Netherlands/Bradford, United Kingdom in 2002 and holds a Bachelor in Business Administration degree from IHBO, Eindhoven, the Netherlands.
Marc Dickie: Head of Global Swine;
Mr. Dickie has been Head of Global Marketing-Swine for Intervet based in Boxmeer since March 2006. Prior to this Mr. Dickie was Head of Marketing and Sales for the company in Austria. He also held a number of consultancy positions and for the period of 1986 to 1993 he was an Assistant Professor at the Veterinary University, Vienna, Austria. Mr. Dickie holds a PhD from the Veterinary University, Vienna, Austria obtained in 1989.
Hank Behrend: Head of Global Aquaculture Pharmaceuticals;
Mr. Behrend joined Schering-Plough in 1981 and has held the position of Sr. Director, Global Aquaculture at Schering-Plough Animal Health since 2002. Mr. Behrend held several positions within the Agricultural Division of American Cyanamid and was also a Research Technician, Manager of Research Farms and held various International Marketing positions at E.R. Squibb and Sons. Mr. Behrend holds a Masters degree in Animal Science from Rutgers University, New Jersey, USA and a Bachelors degree in Animal Science from Delaware Valley College of Science and Agriculture, USA.
Alistair Brown: Head of Global Aquaculture Biologicals;
Mr. Brown has been Head of Aquatic Animal Health for Intervet, based in Boxmeer, the Netherlands since 2001. He joined the company in 1995 in Norway and became General Manager of Intervet Norbio AS, Intervet’s subsidiary in Norway, responsible for cold water aquatic animal health in 1999. Mr. Brown holds a Masters degree in Science and a Post-Graduate Diploma in Economics, specializing in Fisheries and Aquaculture from the University of Portsmouth, United Kingdom.
The Global Species teams are responsible for the marketing strategies in the regional markets. The teams work closely with R&D to maintain a successful pipeline of new products.
The new combination Intervet/Schering-Plough Animal Health strengthens the animal health portfolio in several areas and brings together complementary lines of pharmaceuticals, biologicals and an enhanced science and technology platform. This ensures on-going commitment to meeting the challenges of the various species segments. Intervet/Schering-Plough Animal Health is not only the world market leader in the production of animal health vaccines, but is also one of the world’s leaders in the field of animal health.
###
Note for the editor
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough’s vision is to “Earn Trust, Every Day” with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its website is www.schering-plough.com.”
For more information about Intervet/Schering-Plough Animal Health visit the following website: www.intervet.com www.spah.com
